product name: | inosine |
synonyms: | atorel;beta-d-ribofuranoside, hypoxanthine-9;beta-inosine;hxr;hypoxanthine d-riboside;hypoxanthine, 9-beta-d-ribofuranosyl-;hypoxanthined-riboside;hypoxanthinenucleoside |
cas: | 58-63-9 |
mf: | c10h12n4o5 |
mw: | 268.23 |
einecs: | 200-390-4 |
product categories: | nucleotides and nucleosides;antivirals for research and experimental use;biochemistry;nucleosides and their analogs;nucleosides, nucleotides & related reagents;nucleic acids;bases & related reagents;nucleotides;inhibitors |
inosine chemical properties |
mp | 222-226 °c (dec.)(lit.) |
alpha | -49.2 º (c=1,h2o 18 ºc) |
bp | 226 c (dec.) |
refractive index | -52 ° (c=1, h2o) |
storage temp. | store at rt. |
solubility | h2o: 0.5 m, clear, colorless |
water solubility | 2.1 g/100 ml (20 ºc) |
merck | 14,4975 |
brn | 624889 |
stability: | hygroscopic |
cas database reference | 58-63-9(cas database reference) |
nist chemistry reference | inosine(58-63-9) |
epa substance registry system | inosine(58-63-9) |
safety information |
hazard codes | xi |
risk statements | 36/37/38 |
safety statements | 24/25-36-26 |
wgk germany | 2 |
rtecs | nm7460000 |
f | 10 |
inosine usage and synthesis |
chemical properties | white crystalline powder |
usage | has neuroprotective properties improving axonal wiring. has been used to treat stroke patients to restore neural function. |
usage | cell function activator, cardiotonic |